Harmonization study of antibodies and platforms for programmed death ligand 1 immunostaining in non-small cell lung cancer: does shuffling couples settle the troubles?

被引：2
作者：
Kashima, Jumpei [1 ]
Okuma, Yusuke [2 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pathol, Tokyo, Japan
[2] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
PD-L1; IMMUNOHISTOCHEMISTRY;
D O I：
10.21037/jtd.2018.06.116
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S2124 / S2126
页数：3
相关论文
共 9 条
  • [1] Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
    Adam, J.
    Le Stang, N.
    Rouquette, I.
    Cazes, A.
    Badoual, C.
    Pinot-Roussel, H.
    Tixier, L.
    Danel, C.
    Damiola, F.
    Damotte, D.
    Penault-Llorca, F.
    Lantuejoul, S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 953 - 958
  • [2] Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
    Hellmann, M. D.
    Ciuleanu, T. -E.
    Pluzanski, A.
    Lee, J. S.
    Otterson, G. A.
    Audigier-Valette, C.
    Minenza, E.
    Linardou, H.
    Burgers, S.
    Salman, P.
    Borghaei, H.
    Ramalingam, S. S.
    Brahmer, J.
    Reck, M.
    O'Byrne, K. J.
    Geese, W. J.
    Green, G.
    Chang, H.
    Szustakowski, J.
    Bhagavatheeswaran, P.
    Healey, D.
    Fu, Y.
    Nathan, F.
    Paz-Ares, L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) : 2093 - 2104
  • [3] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
    Herbst, Roy S.
    Baas, Paul
    Kim, Dong-Wan
    Felip, Enriqueta
    Perez-Gracia, Jose L.
    Han, Ji-Youn
    Molina, Julian
    Kim, Joo-Hang
    Arvis, Catherine Dubos
    Ahn, Myung-Ju
    Majem, Margarita
    Fidler, Mary J.
    de Castro, Gilberto, Jr.
    Garrido, Marcelo
    Lubiniecki, Gregory M.
    Shentu, Yue
    Im, Ellie
    Dolled-Filhart, Marisa
    Garon, Edward B.
    [J]. LANCET, 2016, 387 (10027) : 1540 - 1550
  • [4] PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
    Hirsch, Fred R.
    McElhinny, Abigail
    Stanforth, Dave
    Ranger-Moore, James
    Jansson, Malinka
    Kulangara, Karina
    Richardson, William
    Towne, Penny
    Hanks, Debra
    Vennapusa, Bharathi
    Mistry, Amita
    Kalamegham, Rasika
    Averbuch, Steve
    Novotny, James
    Rubin, Eric
    Emancipator, Kenneth
    McCaffery, Ian
    Williams, J. Andrew
    Walker, Jill
    Longshore, John
    Tsao, Ming Sound
    Kerr, Keith M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 208 - 222
  • [5] A Harmonization Study for the Use of 22C3 PD-L1 Immunohistochemical Staining on Ventana's Platform
    Neuman, Tzahi
    London, Michal
    Kania-Almog, Juliane
    Litvin, Anna
    Zohar, Yaniv
    Fridel, Ludmila
    Sandbank, Judith
    Barshak, Iris
    Vainer, Gilad W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1863 - 1868
  • [6] Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scott, Marietta
    Scorer, Paul
    Al-Masri, Hytham
    Rebelatto, Marlon C.
    Walker, Jill
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3585 - 3591
  • [7] Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
    Reck, Martin
    Rodriguez-Abreu, Delvys
    Robinson, Andrew G.
    Hui, Rina
    Csoszi, Tibor
    Fulop, Andrea
    Gottfried, Maya
    Peled, Nir
    Tafreshi, Ali
    Cuffe, Sinead
    O'Brien, Mary
    Rao, Suman
    Hotta, Katsuyuki
    Leiby, Melanie A.
    Lubiniecki, Gregory M.
    Shentu, Yue
    Rangwala, Reshma
    Brahmer, Julie R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1823 - 1833
  • [8] A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer
    Rimm, David L.
    Han, Gang
    Taube, Janis M.
    Yi, Eunhee S.
    Bridge, Julia A.
    Flieder, Douglas B.
    Homer, Robert
    West, William W.
    Wu, Hong
    Roden, Anja C.
    Fujimoto, Junya
    Yu, Hui
    Anders, Robert
    Kowalewski, Ashley
    Rivard, Christopher
    Rehman, Jamaal
    Batenchuk, Cory
    Burns, Virginia
    Hirsch, Fred R.
    Wistuba, Ignacio I.
    [J]. JAMA ONCOLOGY, 2017, 3 (08) : 1051 - 1058
  • [9] Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
    Scheel, Andreas H.
    Dietel, Manfred
    Heukamp, Lukas C.
    Joehrens, Korinna
    Kirchner, Thomas
    Reu, Simone
    Rueschoff, Josef
    Schildhaus, Hans-Ulrich
    Schirmacher, Peter
    Tiemann, Markus
    Warth, Arne
    Weichert, Wilko
    Fischer, Rieke N.
    Wolf, Juergen
    Buettner, Reinhard
    [J]. MODERN PATHOLOGY, 2016, 29 (10) : 1165 - 1172
1